Together, these findings have a substantial impact on our understanding of the potential mechanisms through which genetic variation at the GBA1-GBAP1 locus could explain phenotypic diversity in GD and modulate disease risk and expressivity in PD. This evidence concerns the gene GBA1 and Parkinson disease.